NCT04664595View on ClinicalTrials.gov

Requirements of Propofol With Target Controlled Infusions for Supraglottic Airway Devices

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

December 31, 2013

Conditions
Appropriate AffectComplication of Device Insertion
Interventions
DRUG

Propofol Fresenius

final dose of Propofol (mcg/kg) to reach the target effect-site concentration

Trial Locations (2)

90110

Price of Songkla University, Hat Yai

Songklanagarind Hospital, Hat Yai

All Listed Sponsors
lead

Prince of Songkla University

OTHER

NCT04664595 - Requirements of Propofol With Target Controlled Infusions for Supraglottic Airway Devices | Biotech Hunter | Biotech Hunter